» Articles » PMID: 26393889

A Prussian Blue-Based Core-Shell Hollow-Structured Mesoporous Nanoparticle As a Smart Theranostic Agent with Ultrahigh PH-Responsive Longitudinal Relaxivity

Overview
Journal Adv Mater
Date 2015 Sep 23
PMID 26393889
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

Novel core-shell hollow mesoporous Prussian blue @ Mn-containing Prussian blue analogue (HMPB@MnPBA) nanoparticles, designated as HMPB-Mn) as an intelligent theranostic nanoagent, are successfully constructed by coating a similarly crystal-structured MnPBA onto HMPB. This can be used as a pH-responsive T1 -weighted magnetic resonance imaging contrast agent with ultrahigh longitudinal relaxivity (r1 = 7.43 m m(-1) s(-1) ), and achieves the real-time monitoring of drug release.

Citing Articles

Unconventional hexagonal open Prussian blue analog structures.

Yin J, Wang J, Sun M, Yang Y, Lyu J, Wang L Nat Commun. 2025; 16(1):370.

PMID: 39753576 PMC: 11698902. DOI: 10.1038/s41467-024-55775-w.


Designing Mesoporous Prussian Blue@zinc Phosphate Nanoparticles with Hierarchical Pores for Varisized Guest Delivery and Photothermally-Augmented Chemo-Starvation Therapy.

Yuan Y, Hou M, Song X, Yao X, Wang X, Chen X Int J Nanomedicine. 2024; 19:6829-6843.

PMID: 39005958 PMC: 11244623. DOI: 10.2147/IJN.S464186.


Apatinib and gamabufotalin co-loaded lipid/Prussian blue nanoparticles for synergistic therapy to gastric cancer with metastasis.

Chen B, Zhao Y, Lin Z, Liang J, Fan J, Huang Y J Pharm Anal. 2024; 14(5):100904.

PMID: 38779391 PMC: 11109468. DOI: 10.1016/j.jpha.2023.11.011.


Relief of tumor hypoxia using a nanoenzyme amplifies NIR-II photoacoustic-guided photothermal therapy.

Xue Q, Zeng S, Ren Y, Pan Y, Chen J, Chen N Biomed Opt Express. 2024; 15(1):59-76.

PMID: 38223179 PMC: 10783917. DOI: 10.1364/BOE.499286.


Biohybrid Nanoparticle-Based In Situ Monitoring of In Vivo Drug Delivery.

Ju S, Cho H Biosensors (Basel). 2023; 13(12).

PMID: 38131776 PMC: 10741677. DOI: 10.3390/bios13121017.